FDA Expands Market Access, Authorizes New ENDS Products
The FDA authorized the marketing of four specific electronic nicotine delivery systems (ENDS) from the manufacturer Glas through the premarket tobacco product application (PMTA) pathway.
This affects the manufacturer Glas, as well as regulatory and compliance professionals involved in the ENDS and tobacco industries responsible for PMTA filings and product launches.
This authorization indicates that the manufacturer provided sufficient evidence to meet the necessary regulatory standards for marketing new tobacco products. For industry professionals, it confirms the continued utilization of the PMTA pathway as a viable route for market access for ENDS products that can demonstrate they are appropriate for the protection of public health. This suggests that the FDA is actively processing and granting orders for electronic nicotine delivery systems that meet their specific evidentiary requirements.
Regulatory teams should verify that all authorized ENDS products strictly adhere to the specific marketing and design parameters outlined in their PMTA approval. Ensure that any post-market reporting requirements are integrated into existing compliance workflows to maintain authorization status. Verify that labeling and distribution channels align with the authorized order.
FDA today authorized the marketing of four Glas electronic nicotine delivery systems (ENDS) through the premarket tobacco product application (PMTA) pathway.
Open in openFDA / FDA.gov